全文获取类型
收费全文 | 183833篇 |
免费 | 1463篇 |
国内免费 | 27篇 |
专业分类
耳鼻咽喉 | 1287篇 |
儿科学 | 6829篇 |
妇产科学 | 3189篇 |
基础医学 | 17507篇 |
口腔科学 | 1795篇 |
临床医学 | 13410篇 |
内科学 | 32112篇 |
皮肤病学 | 721篇 |
神经病学 | 17323篇 |
特种医学 | 9225篇 |
外科学 | 30382篇 |
综合类 | 2387篇 |
一般理论 | 11篇 |
预防医学 | 18931篇 |
眼科学 | 2866篇 |
药学 | 9915篇 |
中国医学 | 630篇 |
肿瘤学 | 16803篇 |
出版年
2021年 | 142篇 |
2020年 | 110篇 |
2019年 | 179篇 |
2018年 | 22066篇 |
2017年 | 17509篇 |
2016年 | 19634篇 |
2015年 | 1087篇 |
2014年 | 1047篇 |
2013年 | 1153篇 |
2012年 | 7473篇 |
2011年 | 21519篇 |
2010年 | 19081篇 |
2009年 | 11771篇 |
2008年 | 19974篇 |
2007年 | 22241篇 |
2006年 | 1144篇 |
2005年 | 2760篇 |
2004年 | 3948篇 |
2003年 | 4885篇 |
2002年 | 2986篇 |
2001年 | 348篇 |
2000年 | 476篇 |
1999年 | 244篇 |
1998年 | 296篇 |
1997年 | 294篇 |
1996年 | 141篇 |
1995年 | 183篇 |
1994年 | 176篇 |
1993年 | 124篇 |
1992年 | 98篇 |
1991年 | 140篇 |
1990年 | 177篇 |
1989年 | 123篇 |
1988年 | 95篇 |
1987年 | 82篇 |
1986年 | 59篇 |
1985年 | 86篇 |
1984年 | 69篇 |
1983年 | 79篇 |
1982年 | 85篇 |
1981年 | 61篇 |
1980年 | 98篇 |
1979年 | 43篇 |
1978年 | 58篇 |
1976年 | 48篇 |
1974年 | 44篇 |
1970年 | 53篇 |
1938年 | 62篇 |
1932年 | 57篇 |
1930年 | 46篇 |
排序方式: 共有10000条查询结果,搜索用时 218 毫秒
1.
2.
3.
Neil Ryan Johanna Wall Emma J Crosbie Mark Arends Tjalling Bosse Saimah Arif Asma Faruqi Ian Frayling Raji Ganesan Ye L Hock Raymond McMahon Ranjit Manchanda W Glenn McCluggage Pinias Mukonoweshuro Gerhard van Schalkwyk Lucy Side John H Smith Bruce Tanchel D Gareth Evans C Blake Gilks Naveena Singh 《Histopathology》2019,75(6):813-824
4.
5.
Grant R. Williams Kathryn E. Weaver Glenn J. Lesser Emily Dressler Karen M. Winkfield Heather B. Neuman Anne E. Kazak Ruth Carlos Lucy J. Gansauer Charles S. Kamen Joseph M. Unger Supriya G. Mohile Heidi D. Klepin 《The oncologist》2020,25(12):1032-1038
BackgroundAmerican Society of Clinical Oncology guidelines recommend that patients ≥65 years of age starting chemotherapy undergo a geriatric assessment (GA) to inform and guide management; however, little is known about resources available in community oncology practices to implement these guidelines and to facilitate geriatric oncology research.Materials and MethodsOncology practices within the National Cancer Institute Community Oncology Research Program (NCORP) were electronically surveyed in 2017 regarding the availability of specialty providers, supportive services, and practice characteristics, as part of a larger survey of cancer care delivery research capacity.ResultsOf the 943 NCORP practices, 504 (54%) responded to the survey, representing 210 practice groups. The median new cancer cases per year ≥65 years of age was 457 (interquartile range 227–939). Of respondents, only 2.0% of practices had a fellowship‐trained geriatric oncologist on staff. Geriatricians were available for consultation or comanagement at 37% of sites, and of those, only 13% had availability within the oncology clinic (5% of overall). Practice size of ≥1,000 new adult cancer cases (ages ≥18) per year was associated with higher odds (1.81, confidence interval 1.02–3.23) of geriatrician availability. Other multidisciplinary care professionals that could support GA were variably available onsite: social worker (84%), nurse navigator (81%), pharmacist (77%), dietician (71%), rehabilitative medicine (57%), psychologist (42%), and psychiatrist (37%).ConclusionOnly a third of community oncology practices have access to a geriatrician within their group and only 5% of community sites have access within the oncology clinic. Use of primarily self‐administered GA tools that direct referrals to available services may be an effective implementation strategy for guideline‐based care.Implications for PracticeOnly a minority of community oncology practices in the U.S. have access to geriatric specialty care. Developing models of care that use patient‐reported measures and/or other geriatric screening tools to assess and guide interventions in older adults, rather than geriatric consultations, are likely the most practical methods to improve the care of this vulnerable population. 相似文献
6.
7.
Huinan Zhang Jingru Meng Shimeng Zhou Yunhan Liu Di Qu Ling Wang Xubo Li Ning Wang Xiaoxing Luo Xue Ma 《The AAPS journal》2016,18(2):385-394
Exendin-4 is now considered as a promising drug for the treatment of cerebral ischemia. To determine the neuroprotective effects of intranasal exendin-4, C57BL/6J mice were intranasally administered with exendin-4 daily for 7 days before middle cerebral artery occlusion (MCAO) surgery. Intranasally administered exendin-4 produced higher brain concentrations and lower plasma concentrations when compared to identical doses administered interperitoneally. Neurological deficits and volume of infarcted lesions were analyzed 24 h after ischemia. Intranasal administration of exendin-4 exhibited significant neuroprotection in C57BL/6 mice subjected to MCAO by reducing neurological deficit scores and infarct volume. The neuroprotective effects of exendin-4 were blocked by the knockdown of GLP-1R with shRNA. However, exendin-4 has no impact on glucose and insulin levels which indicated that the neuroprotective effect was mediated by the activation of GLP-1R in the brain. Exendin-4 intranasal administration restored the balance between pro- and anti-apoptotic proteins and decreased the expression of Caspase-3. The anti-apoptotic effect was mediated by the cAMP/PKA and PI3K/Akt pathway. These findings provided evidence that exendin-4 intranasal administration exerted a neuroprotective effect mediated by an anti-apoptotic mechanism in MCAO mice and protected neurons against ischemic injury through the GLP-1R pathway in the brain. Intranasal delivery of exendin-4 might be a promising strategy for the treatment of ischemic stroke. 相似文献
8.
9.
10.
This study charts pathways through message resistance to enhance the persuasiveness of diabetes self-care messages. A 2 (narrative) × 2 (other-referencing) × 2 (message) × 4 (order) experiment with adult diabetics (N = 58) tested whether packaging overt recommendations as a story rather than an informational argument (i.e., narrative structure) and highlighting the impact of health decisions on family and friends rather than the individual (i.e., other-referencing) can effectively attenuate psychological reactance to messages encouraging healthy diet and physical activity. Narrative and other-referencing each led to lower perceived threat to choice, less state anger and counterarguing, less negative cognitive responses, more positive attitudes toward the ad and the behaviors promoted, and greater intended compliance with message recommendations. Findings illustrate two strategies that communicators may employ in order to benefit from clear, direct health messages while avoiding the reactance they may provoke. Moreover, findings inform message design for diabetes self-care education. 相似文献